ロード中...
Epirubicin/paclitaxel/etoposide in extensive-stage small-cell lung cancer: a phase I–II study
The aim of this study was to evaluate feasibility and toxicity of escalating doses of epirubicin and paclitaxel plus fixed dose of etoposide and to define the activity of the triplet in extensive disease small-cell lung cancer. Thirteen patients entered the phase I study: the maximum tolerated doses...
保存先:
| 主要な著者: | , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group
2006
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2361402/ https://ncbi.nlm.nih.gov/pubmed/16622468 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603074 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|